结核病的微生物学

Julià Gonzàlez-Martin
{"title":"结核病的微生物学","authors":"Julià Gonzàlez-Martin","doi":"10.1016/j.semreu.2014.01.001","DOIUrl":null,"url":null,"abstract":"<div><p>Tuberculosis (TB) is one of the infectious diseases with a larger number of cases, especially in low-income countries. Despite having an effective treatment, its control is difficult due to the characteristics of the bacterium and the transmission mechanism of the disease. The microbiological diagnosis establishes the etiology and confirms the disease. It is based on specific staining microscopy, mycobacterial culture, especially liquid media, and gene amplification, when the suspicion is moderate to high. It is always necessary to identify positive cultures, since in the recent years an increase in non-tuberculous <em>Mycobacteria</em> (NMT), with different TB treatment, has been observed. The treatment of resistant cases is complicated and also limited due to the lack of alternative drugs. Therefore, systematic susceptibility testing should be performed on all patients with positive isolates. The screening of the mutations associated with resistance provides information in 2-3<!--> <!-->days instead of 3-4<!--> <!-->weeks. It is indicated in previously treated patients, contacts with resistant cases, in clinical failures or recurrences, and in patients originating from countries with a high incidence of TB.</p><p>New diagnostic tests are needed to improve the current limitations of these tests, such as the sensitivity and slow growth rate of <em>Mycobacterium tuberculosis</em>.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"15 1","pages":"Pages 25-33"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2014.01.001","citationCount":"8","resultStr":"{\"title\":\"Microbiología de la tuberculosis\",\"authors\":\"Julià Gonzàlez-Martin\",\"doi\":\"10.1016/j.semreu.2014.01.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Tuberculosis (TB) is one of the infectious diseases with a larger number of cases, especially in low-income countries. Despite having an effective treatment, its control is difficult due to the characteristics of the bacterium and the transmission mechanism of the disease. The microbiological diagnosis establishes the etiology and confirms the disease. It is based on specific staining microscopy, mycobacterial culture, especially liquid media, and gene amplification, when the suspicion is moderate to high. It is always necessary to identify positive cultures, since in the recent years an increase in non-tuberculous <em>Mycobacteria</em> (NMT), with different TB treatment, has been observed. The treatment of resistant cases is complicated and also limited due to the lack of alternative drugs. Therefore, systematic susceptibility testing should be performed on all patients with positive isolates. The screening of the mutations associated with resistance provides information in 2-3<!--> <!-->days instead of 3-4<!--> <!-->weeks. It is indicated in previously treated patients, contacts with resistant cases, in clinical failures or recurrences, and in patients originating from countries with a high incidence of TB.</p><p>New diagnostic tests are needed to improve the current limitations of these tests, such as the sensitivity and slow growth rate of <em>Mycobacterium tuberculosis</em>.</p></div>\",\"PeriodicalId\":101152,\"journal\":{\"name\":\"Seminarios de la Fundación Espa?ola de Reumatología\",\"volume\":\"15 1\",\"pages\":\"Pages 25-33\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.semreu.2014.01.001\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminarios de la Fundación Espa?ola de Reumatología\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1577356614000025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminarios de la Fundación Espa?ola de Reumatología","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1577356614000025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

摘要

结核病(TB)是病例数最多的传染病之一,特别是在低收入国家。尽管有有效的治疗方法,但由于细菌的特点和疾病的传播机制,控制它是困难的。微生物学诊断确定病因并确认疾病。当怀疑程度为中度至高度时,以特异性染色显微镜、分枝杆菌培养(特别是液体培养基)和基因扩增为基础。由于近年来观察到在不同的结核病治疗下,非结核分枝杆菌(NMT)的增加,因此始终有必要确定阳性培养物。耐药病例的治疗很复杂,而且由于缺乏替代药物而受到限制。因此,应对所有阳性分离株患者进行系统的药敏试验。与耐药相关的突变筛选在2-3天而不是3-4周内提供信息。它适用于以前接受过治疗的患者、与耐药病例接触的患者、临床失败或复发患者以及来自结核病高发国家的患者。需要新的诊断测试来改善目前这些测试的局限性,例如结核分枝杆菌的敏感性和缓慢的生长速度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Microbiología de la tuberculosis

Tuberculosis (TB) is one of the infectious diseases with a larger number of cases, especially in low-income countries. Despite having an effective treatment, its control is difficult due to the characteristics of the bacterium and the transmission mechanism of the disease. The microbiological diagnosis establishes the etiology and confirms the disease. It is based on specific staining microscopy, mycobacterial culture, especially liquid media, and gene amplification, when the suspicion is moderate to high. It is always necessary to identify positive cultures, since in the recent years an increase in non-tuberculous Mycobacteria (NMT), with different TB treatment, has been observed. The treatment of resistant cases is complicated and also limited due to the lack of alternative drugs. Therefore, systematic susceptibility testing should be performed on all patients with positive isolates. The screening of the mutations associated with resistance provides information in 2-3 days instead of 3-4 weeks. It is indicated in previously treated patients, contacts with resistant cases, in clinical failures or recurrences, and in patients originating from countries with a high incidence of TB.

New diagnostic tests are needed to improve the current limitations of these tests, such as the sensitivity and slow growth rate of Mycobacterium tuberculosis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信